A detailed history of Intech Investment Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 192,549 shares of GILD stock, worth $17.4 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
192,549
Previous 274,384 29.82%
Holding current value
$17.4 Million
Previous $18.8 Million 14.27%
% of portfolio
0.18%
Previous 0.24%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$66.59 - $83.99 $5.45 Million - $6.87 Million
-81,835 Reduced 29.82%
192,549 $16.1 Million
Q2 2024

Aug 12, 2024

SELL
$63.15 - $72.88 $580,474 - $669,912
-9,192 Reduced 3.24%
274,384 $18.8 Million
Q1 2024

May 10, 2024

SELL
$71.58 - $87.29 $6.41 Million - $7.82 Million
-89,530 Reduced 24.0%
283,576 $20.8 Million
Q4 2023

Oct 18, 2024

SELL
$73.27 - $83.09 $10.3 Million - $11.7 Million
-141,024 Reduced 27.43%
373,106 $30.2 Million
Q4 2023

Feb 09, 2024

SELL
$73.27 - $83.09 $10.3 Million - $11.7 Million
-141,024 Reduced 27.43%
373,106 $30.2 Million
Q3 2023

Oct 18, 2024

SELL
$73.94 - $80.67 $31.6 Million - $34.5 Million
-427,793 Reduced 45.42%
514,130 $38.5 Million
Q3 2023

Nov 13, 2023

SELL
$73.94 - $80.67 $32.6 Million - $35.6 Million
-441,243 Reduced 46.19%
514,130 $38.5 Million
Q2 2023

Oct 18, 2024

SELL
$76.01 - $86.7 $55.8 Million - $63.7 Million
-734,420 Reduced 43.81%
941,923 $72.6 Million
Q2 2023

Aug 09, 2023

SELL
$76.01 - $86.7 $55.3 Million - $63 Million
-727,021 Reduced 43.21%
955,373 $73.6 Million
Q1 2023

Oct 18, 2024

BUY
$77.31 - $88.08 $108 Million - $123 Million
1,401,959 Added 510.95%
1,676,343 $139 Million
Q1 2023

May 10, 2023

BUY
$77.31 - $88.08 $5.52 Million - $6.29 Million
71,446 Added 4.44%
1,682,394 $140 Million
Q4 2022

Oct 18, 2024

SELL
$62.32 - $89.47 $28.3 Million - $40.7 Million
-454,557 Reduced 22.05%
1,607,295 $138 Million
Q4 2022

Feb 09, 2023

SELL
$62.32 - $89.47 $28.1 Million - $40.3 Million
-450,904 Reduced 21.87%
1,610,948 $138 Million
Q3 2022

Oct 18, 2024

BUY
$59.54 - $68.01 $106 Million - $122 Million
1,787,468 Added 651.45%
2,061,852 $127 Million
Q3 2022

Nov 10, 2022

SELL
$59.54 - $68.01 $6.97 Million - $7.96 Million
-117,023 Reduced 5.37%
2,061,852 $127 Million
Q2 2022

Aug 10, 2022

BUY
$57.72 - $65.01 $126 Million - $142 Million
2,178,875 New
2,178,875 $135 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.